PATENT CLAIM ANALYSIS

Application Number: 15867097
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds of formula I wherein R 1  is hydrogen, F or Cl; L is a bond or lower alkylene; R 2  is —(CH 2 ) n O-lower alkyl, lower alkyl substituted by halogen, —(CH 2 ) n C(O)O-lower alkyl, phenyl substituted by lower alkyl or halogen, or is a 5 or 6-membered heteroaryl group, selected from pyridinyl, pyrimidinyl, pyridazinyl, thiazolyl, imidazolyl, pyrazolyl or triazolyl, which are optionally substituted by lower alkyl, halogen, lower alkoxy, ═O, benzyloxy, cycloalkyloxy, hydroxy, cyano, lower alkyl substituted by halogen, or by —(CH 2 ) n O-lower alkyl;      n is 1, 2 or 3;       R 3  is hydrogen, lower alkyl or —(CH 2 ) n O-lower alkyl; R 4  is phenyl, pyridinyl or pyrimidinyl, optionally substituted by F; Y is CF or CCl; or to a pharmaceutically acceptable salt or acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomers thereof.  The compounds may be used for the treatment of Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.

Claim (Index 1):
A compound of formula I wherein R 1  is hydrogen, F or Cl; L is a bond or lower alkylene; R 2  is \u2014(CH 2 ) n O-lower alkyl, lower alkyl substituted by halogen, \u2014(CH 2 ) n C(O)O-lower alkyl, phenyl substituted by lower alkyl or halogen, or is a 5 or 6-membered heteroaryl group, selected from pyridinyl, pyrimidinyl, pyridazinyl, thiazolyl, imidazolyl, pyrazolyl or triazolyl, which are optionally substituted by lower alkyl, halogen, lower alkoxy, \u2550O, benzyloxy, cycloalkyloxy, hydroxy, cyano, lower alkyl substituted by halogen, or by \u2014(CH 2 ) n O-lower alkyl;\n n is 1, 2 or 3; \n R 3  is hydrogen, lower alkyl or \u2014(CH 2 ) n O-lower alkyl; R 4  is phenyl, pyridinyl or pyrimidinyl, each optionally substituted by F; Y is CF or CCl; or a pharmaceutically acceptable salt or acid addition salt, a racemic mixture, or its corresponding enantiomer and/or optical isomer and/or stereoisomers thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 2.32353
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15245955', '15283010', '15707848', '15205466', '10592222']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7785581131635053
- 35 USC 102 Novelty (BERT): 0.6348407440702336
- Combined Prediction Score: 0.7641863762541781
- Mean Citation Score: 401.266512
- Max Citation Score: 632.2413
- Similarity Product: 520.7285902795314

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test